| Market Cap | 7.61M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -19.6M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -2.00% |
| Sales | 70.65M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -23.00% |
| Dividend | N/A | Price/Book | 1.58 | EPS next 5Y | - | 52W High Chg | -71.00% |
| Recommedations | 3.00 | Quick Ratio | 0.06 | Shares Outstanding | 302.18M | 52W Low Chg | 38.00% |
| Insider Own | 14.51% | ROA | -12.08% | Shares Float | 264.85M | Beta | 1.31 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.04 |
| Gross Margin | 17.77% | Profit Margin | -27.74% | Avg. Volume | 7,125 | Target Price | - |
| Oper. Margin | -17.94% | Earnings Date | Nov 12 | Volume | 500 | Change | -6.34% |
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.
